A Rapid Mapping Review of Medication Burden in Adults with an Intellectual Disability: What We Know and What We Do Not Know

Drug, Healthcare and Patient Safety · Published 2026-03-01 · DOI 10.2147/dhps.s558001

Authors being retrieved — see the publisher record. https://doi.org/10.2147/dhps.s558001

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

A protocol for application of OPTIMA-ID to identify potentially inappropriate prescribing in a cohort of older adults with intellectual disability · HRB Open Research · 2026 · Cites or is cited by this article
Assessing Readability and Usability of Electronic Medicine Package Leaflets in South Korea: A Mixed-Methods Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
Obstructive Fibrinous Tracheal Pseudomembrane Following Repeated Intratracheal Interventions · Drug, Healthcare and Patient Safety · 2024 · Same journal
Paracetamol Overdose in Somali Children Under Five: An Emerging Public Health Concern · Drug, Healthcare and Patient Safety · 2025 · Same journal
Assessment of Knowledge, Attitudes, and Practices on Antibiotic Use and Resistance Among Healthcare Workers in Monrovia, Liberia: A Facility-Based Cross-Sectional Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
Prevalence of Missed Medication Doses and Outcomes of Hospitalized Patients Living with HIV in Uganda · Drug, Healthcare and Patient Safety · 2026 · Same journal
Establishing of a National Diagnostic Reference Level for Radiation Dose in Digital Paediatric Pelvic X-Rays in Jordan: A Multicenter Retrospective Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
The Prevalence and Severity of Potential Drug–Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital · Drug, Healthcare and Patient Safety · 2023 · Same journal
Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome · Drug, Healthcare and Patient Safety · 2024 · Same journal
Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal · Drug, Healthcare and Patient Safety · 2023 · Same journal